IGC Pharma (IGC) Price to FCF (2010 - 2025)

IGC Pharma (IGC) has reported Price to FCF for 16 consecutive years, with 27.96 the latest figure, recorded in Q3 2025.

• On a quarterly basis, Price to FCF rose 12.39% year-over-year to 27.96 in Q3 2025; TTM through Sep 2025 was 6.81, a 4.37% decrease from a year earlier, with the FY2026 full-year figure at 21.23, down 351.91% from the prior year.
• Price to FCF was 27.96 for Q3 2025 at IGC Pharma, down from 11.9 in the prior quarter.
• Over five years, Price to FCF peaked at 7.57 in Q4 2022 and troughed at 49.89 in Q1 2022.
• A 5-year average of 23.74 and a median of 19.55 in 2024 frame the typical range for Price to FCF.
• Across the five-year window, Price to FCF slumped 714.12% in 2021 and soared 76.27% in 2023, its largest moves.
• Over 5 years, Price to FCF stood at 20.36 in 2021, then soared by 62.81% to 7.57 in 2022, then tumbled by 42.47% to 10.79 in 2023, then plunged by 81.25% to 19.55 in 2024, then slumped by 43.03% to 27.96 in 2025.
• The last three Price to FCF figures came in at 27.96 (Q3 2025), 11.9 (Q2 2025), and 30.82 (Q1 2025), per Business Quant data.